What are the characteristic histologic features of hepatitis B virus infection compared to hepatitis C virus infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Histological Patterns of Hepatitis B and C

Hepatitis C demonstrates four characteristic histological features that distinguish it from hepatitis B: bile duct damage, lymphoid follicles/aggregates in portal tracts, large-droplet steatosis, and Mallory body-like material—with the latter being virtually pathognomonic for HCV when present. 1

Key Distinguishing Features

Hepatitis C-Specific Patterns

Bile duct damage is 4.7 times more likely in HCV than HBV infection, manifesting as injury to interlobular bile ducts within portal tracts. 1 This feature, while not exclusive to HCV, represents a critical diagnostic clue when evaluating chronic viral hepatitis. 1

Lymphoid aggregates and follicles appear 2.4 times more frequently in HCV, presenting as well-defined collections of lymphocytes within portal areas. 2, 1 These structures are essentially absent in isolated HBV infection but may appear in coinfection scenarios. 2

Steatosis (large-droplet fat) occurs 2.4 times more commonly in HCV-infected livers compared to HBV. 1 This macrovesicular fat accumulation represents a direct cytopathic effect of the virus on hepatocyte lipid metabolism. 1

Mallory body-like material in hepatocytes is seen exclusively in HCV infection with an odds ratio of 71.6, making it the most specific histological marker when present. 1 However, this feature is not consistently found in all HCV cases. 1

Hepatitis B-Specific Patterns

Ground-glass hepatocytes are the pathognomonic feature of HBV infection, representing cytoplasmic accumulation of HBsAg in hepatocytes. 3, 2 These cells appear with finely granular, eosinophilic cytoplasm and are found in 66.7% of isolated HBV infections. 3 This feature is absent in isolated HCV infection but may be present in coinfection. 2

Sanded nuclei (representing HBcAg accumulation) are characteristic of active HBV replication. 4 These appear as finely granular nuclear material on routine staining. 4

Shared Histological Features

Both HBV and HCV demonstrate similar patterns of:

  • Interface hepatitis (periportal necroinflammation extending into the lobule) 5, 4
  • Portal lymphoplasmacytic infiltration 5, 4
  • Lobular necroinflammation with varying degrees of hepatocyte injury 4, 6
  • Progressive fibrosis beginning in portal tracts and advancing to cirrhosis 5, 4

Critical Differences in Disease Progression

Hepatitis C represents a continuous disease process without distinct immunological phases, contrasting sharply with HBV's well-defined immune tolerance, immune clearance, low replication, and reactivation phases. 7, 8 This fundamental difference means HCV histology reflects ongoing chronic inflammation rather than phase-specific patterns seen in HBV. 7

HCV progresses to cirrhosis in 15-30% of patients over 20 years, with fibrosis advancing steadily regardless of aminotransferase levels. 8 In contrast, HBV patients in immune tolerance may show minimal histological changes despite high viral loads. 5

Coinfection Patterns

When HBV and HCV coexist, the histological picture becomes complex:

  • More severe fibrosis develops compared to monoinfection (mean fibrosis score 2.1 vs 1.5 in HCV alone). 3
  • Suppression of one virus typically occurs, with the dominant virus determining the predominant histological pattern. 3, 2
  • Ground-glass hepatocytes appear less frequently (37% vs 66.7% in HBV monoinfection) due to HCV suppression of HBV replication. 3
  • Both bile duct lesions and ground-glass hepatocytes may coexist, indicating dual infection. 2

Practical Diagnostic Algorithm

When evaluating liver histology for viral hepatitis:

  1. Look for ground-glass hepatocytes first → if present, confirms HBV component 3, 2
  2. Assess for bile duct damage → if present, strongly suggests HCV component 1
  3. Identify lymphoid follicles → if present, favors HCV over HBV 2, 1
  4. Evaluate steatosis pattern → large-droplet fat favors HCV 1
  5. Search for Mallory body-like material → if present, virtually diagnostic of HCV 1

Critical Pitfalls to Avoid

Do not rely on necroinflammation severity alone to distinguish HBV from HCV—both can produce identical patterns of interface hepatitis and lobular injury. 2, 4 The specific cytopathic features (ground-glass cells, bile duct damage, lymphoid follicles) provide diagnostic specificity. 2, 1

Adequate tissue sampling is essential: at least 1.5 cm length with sufficient portal tracts (minimum 6-8) to accurately assess fibrosis stage and identify diagnostic features. 5 Inadequate samples may miss focal lesions like ground-glass hepatocytes or lymphoid follicles. 5

Normal aminotransferases do not exclude significant histological disease: 14-24% of HCV patients with persistently normal ALT have more-than-portal fibrosis on biopsy. 8 Similarly, HBV patients in immune tolerance may have normal ALT despite high viral loads and minimal inflammation. 5

Coinfection may mask typical features: when both viruses are present, viral suppression can reduce characteristic findings like ground-glass hepatocytes or detectable HCV RNA, making histological diagnosis more challenging. 3, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.